TITLE

Antitumor and immunomodulatory effects of low-dose 5-FU on hepatoma 22 tumor-bearing mice

AUTHOR(S)
ZHIYUN CAO; ZHIDENG ZHANG; ZHENGRONG HUANG; RONGPING WANG; AILIAN YANG; LIANMING LIAO; JIAN DU
PUB. DATE
April 2014
SOURCE
Oncology Letters;2014, Vol. 7 Issue 4, p1260
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Low-dose 5-fluorouracil (5-FU), a widely used chemotherapeutic, has been reported to have immunomodula- tory effects. This study aimed to evaluate the optimal dose of 5-FU that produces antitumor and immunomodulatory effects. In a hepatoma 22 tumor-bearing mouse model, 0, 10, 20 and 40 mg/kg 5-FU (i.p.) was administered for 10 days. Tumor weight and volume were measured, thymus index (TI) and spleen index (SI) were calculated, and the number of white blood cells (WBCs) and lymphocytes (LYs) were counted following treatment. The percentages of CD3+, CD4+, CD8+ and natural killer (NK) cells were measured by low cytometry. In addition, the body weights of the mice were measured and the average diet consumption was calculated. Administration of 5-FU produced a potent antitumor effect in a dose-dependent manner (P<0.01). At 20 and 40 mg/kg, a significant reduction of body weight and food consumption was observed. TI and SI decreased in the 20- and 40-mg/kg groups (P<0.01) for 10 days. The number of WBCs significantly decreased in each group (P<0.01); however, the number of LYs only decreased in the 40-mg/kg group (P<0.01). Percentages of CD3+ and CD4+ cells were increased in the 10- and 20-mg/kg groups (P<0.01). Thus, 5-FU at 10 mg/kg inhibits tumor growth while maintaining the immune function of the mice. 5-FU may exert its antitumor effect at a low dose with low toxicity and stimulate the host immune system. Future clinical trials taking into account the immunostimulatory capacity of chemotherapeutic agents are desirable for certain patients.
ACCESSION #
94754606

 

Related Articles

  • Cure Research Back in the News.  // Diabetes Health;Nov2006, Vol. 15 Issue 11, p16 

    The article highlights some studies on diabetes treatment. It was reported in the March 24, 2006 issue of "Science" that severely diabetic mice may be able to recover when injected with an immune adjuvant called Freund's complete adjuvant, which consists of a mixture of water, oil and parts of...

  • Prevalent expression of the immunostimulatory MHC class I chain--related molecule is counteracted by shedding in prostate cancer. Wu, Jennifer D.; Higgins, Lily M.; Steinle, Alexander; Cosman, David; Haugk, Kathy; Plymate, Stephen R. // Journal of Clinical Investigation;Aug2004, Vol. 114 Issue 4, p560 

    The MHC class I chain-related molecules (MICs) have previously been shown to be induced on most epithelial tumor cells. Engagement of MIC by the activating immune receptor NKG2D triggers NK cells and augments antigen-specific CTL anti-tumor immunity. The MIC-NKG2D system was proposed to...

  • Immunomodulators.  // Encyclopedic Reference of Molecular Pharmacology;2004, p482 

    A definition of the term "immunomodulators," which refers to a group of mostly stimulatory effectors, is presented.

  • Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse. Mozdzanowska, Krystyna; Zharikova, Darya; Cudic, Mare; Otvos, Laszlo; Gerhard, Walter // Virology Journal;2007, Vol. 4, p118 

    Background: The M2 ectodomain (M2e) of influenza A virus (IAV) strains that have circulated in humans during the past 90 years shows remarkably little structural diversity. Since M2e-specific antibodies (Abs) are capable of restricting IAV replication in vivo but are present only at minimal...

  • Lepidium sativum L. Seeds as a Multifunctional Adjuvant with a Nucleopolyhedrovirus-or Bacillus thuringiensis-based Biopreparation. Alfazairy, A. A.; Alfy, Hanan; Zarif, G.; Karam, Hedaya H. // Egyptian Journal of Biological Pest Control;2014, Vol. 24 Issue 1, p101 

    This is the first report of Lepidium sativum L seed powder as an adjuvant for protecting Spodoptera littoralis nucleopolyhedrovirus (SlNPV) and Bacillus thuringiensis mexicanesis (Btm) from sunlight inactivation. Efficacy of the fine powder of L. sativum seeds, as a solar protectant was assessed...

  • Topical immunomodulators: carcinogenic potential?  // WHO Drug Information;2006, Vol. 20 Issue 1, p13 

    The article presents information on the therapeutic use of pimecrolimus cream Elidel® and tacrolimus ointment Protopic®. These topical immunomodulators were granted local marketing approval in January 2003 and March 2004 respectively. Elidel® is licensed for short-term and intermittent...

  • Treatment of endometriosis with transvaginal ultrasound-guided drainage and recombinant interleukin-2 left in the cysts: a third clinical trial. Acién, Pedro; Velasco, Irene; Acién, Maribel; Quereda, Francisco; Acién, Pedro; Acién, Maribel // Gynecologic & Obstetric Investigation;Apr2010, Vol. 69 Issue 3, p203 

    Background: To analyze the therapeutic results of recombinant interleukin-2 (rIL-2) left in the cysts after transvaginal ultrasound (US)-guided drainage of endometriomas as an alternative to surgery. Methods: Prospective and randomized clinical trial. A total of 25...

  • Immunomodulatory effect of ethanolic extract of Shirishadi compound. Kajaria, Divya; Shankar Tripathi, Jyoti; Kant Tiwari, Shri; Lal Pandey, Bajrangi // AYU: An International Quarterly Journal of Research in Ayurveda;Jul-Sep2013, Vol. 34 Issue 3, p322 

    Immunomodulators are substances that helps to regulate the immune system. The basic mechanisms by which the herbs defend the body against infection have two probable ways- one by destroying pathogens and other by enhancing the body immunity. Shirishadi compound is a polyherbal drug used in...

  • Capecitabine, Alone and in Combination, in the Management of Patients with Colorectal Cancer. Comella, Pasquale; Casaretti, Rossana; Sandomenico, Claudia; Avallone, Antonio; Franco, Luca // Drugs;2008, Vol. 68 Issue 7, p949 

    Capecitabine, an oral prodrug of fluorouracil (5FU), has shown efficacy in terms of progression-free and overall survival at least equivalent to standard folinic acid (leucovorin)-modulated intravenous 5FU bolus regimens in patients with metastatic colorectal cancer. Moreover, capecitabine has...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics